India, July 16 -- DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, has announced a new distribution agreement with Gurugram-based Imperial Life Sciences (ILS), expanding access to the company's SYNTAX(R) platform across India.

Under the agreement, ILS will distribute DNA Script's SYNTAX platform throughout the country, providing local sales, technical support and application expertise to researchers seeking faster, more flexible access to high-quality single-stranded DNA (ssDNA) oligonucleotides.

The agreement with ILS builds on DNA Script's recent expansion of its global distribution network across Latin America and East Asia, extending the availability of the SYNTAX pl...